Press Releases

August 1, 2023 Lupin Receives Approval from US FDA for Turqoz® (Norgestrel and Ethinyl Estradiol Tablets USP)

July 28, 2023 Lupin Foundation Strengthens Lives Program With Its First Mobile Medical Van ; Flag-Off by Health Minister, Government Of Rajasthan

July 27, 2023 Lupin Announces Resolution of USFDA Warning Letter for its Goa and Pithampur Facilities

July 26, 2023 Lupin Receives Approval from TGA Australia for Tiotropium Dry Powder for Inhaler for Treatment of COPD

July 24, 2023 Lupin Digital Health and The American College of Cardiology Announce First-Of-Its-Kind Collaboration to Revolutionize In-home Cardiovascular Care in India with Digital Therapeutics

July 21, 2023 Lupin Receives Tentative Approval from U.S. FDA for Dolutegravir Lamivudine and Tenofovir Alafenamide Tablets

July 21, 2023 Lupin Launches Luforbec® 100/6 for Adult Asthma and COPD Treatment in Germany

July 14, 2023 Lupin Receives Approval from U.S. FDA for Chlorpromazine Hydrochloride Tablets USP

July 11, 2023 Lupin Receives EIR from U.S. FDA for its Pithampur Unit-2 Manufacturing Facility